A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

NCT00554372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

GENETIC: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)

Sponsor

Jennerex Biotherapeutics